“…Proposing materials for drug delivery applications requires testing the developed carriers and not only assume the apparent absence of cytotoxicity of the polymers. In this regard, it is consensual that carriers exhibit new and unique properties, thus generating potential different risks as compared to the raw materials of the same chemistry (Aillon, Xie, El-Gendy, Berkland & Forrest, 2009), as observed in other works (Dionísio, Braz, Corvo, Lourenço, Grenha & da Costa, 2016;Dionísio, Cordeiro, Remuñán-López, Seijo, Rosa da Costa & Grenha, 2013). In this regard, in addition to the evaluation of the polymer and the synthesized derivatives, a preliminary evaluation of LBG-based nanoparticles was further performed using the MTT assay.…”